eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | cystic fibrosis |
| Symptom | |infection |
| Sentences | 124 |
| PubMedID- 25830686 | Maltophilia lung infection in patients with cystic fibrosis. |
| PubMedID- 23403223 | Background: mycobacterium abscessus causes lung infection in patients with cystic fibrosis. |
| PubMedID- 22364820 | Conclusion: genetic modifiers play a significant role in the establishment and timing of persistent pa infection in individuals with cystic fibrosis. |
| PubMedID- 22683550 | P. aeruginosa is also responsible for pulmonary infection of patients with cystic fibrosis . |
| PubMedID- 24614401 | We used antibiotic therapy of chronic lung infection in persons with cystic fibrosis as a model system to assess the influence of key variables of therapy on measures of microbial community perturbation. |
| PubMedID- 20503281 | Pseudomonas aeruginosa (psa) is the most common pathogen to cause chronic lung infection in children with cystic fibrosis (cf), and is associated with an increase in both morbidity and mortality. |
| PubMedID- 20837573 | Objectives: to test the presumption that pseudomonas aeruginosa isolates responsible for initial lung infection in individuals with cystic fibrosis (cf) are invariably susceptible to antipseudomonal agents. |
| PubMedID- 22396480 | This is particularly true for the treatment of pseudomonas infection in patients with cystic fibrosis. |
| PubMedID- 26047157 | Aeruginosa airway infection in persons with cystic fibrosis (cf; mim219700). |
| PubMedID- 20105324 | Background: staphylococcus aureus infection in patients with cystic fibrosis (cf) is frequent and may be due to colonization by a few pathogenic lineages. |
| PubMedID- 25443661 | Nocardia farcinica lung infection in a patient with cystic fibrosis and a lung transplant. |
| PubMedID- 26238926 | Pulmonary mycobacterium abscessus sensu lato infection in patients without cystic fibrosis. |
| PubMedID- 21750293 | Context: early pulmonary infection in children with cystic fibrosis leads to increased morbidity and mortality. |
| PubMedID- 25658563 | Species of the burkholderia cepacia complex are associated with opportunistic infection in patients with cystic fibrosis. |
| PubMedID- 25027418 | Pseudomonas aeruginosa infection is a hallmark of lung disease in cystic fibrosis. |
| PubMedID- 22401602 | Challenges with current inhaled treatments for chronic pseudomonas aeruginosa infection in patients with cystic fibrosis. |
| PubMedID- 26517580 | Neutrophil-associated inflammation during pseudomonas aeruginosa lung infection is a determinant of morbidity in cystic fibrosis (cf). |
| PubMedID- 24260360 | A particularly serious medical problem caused by p. aeruginosa is chronic lung infection associated with cystic fibrosis . |
| PubMedID- 20950421 | M. abscessus has been described as a prevalent ntm infection in children with cystic fibrosis 9. |
| PubMedID- 25657265 | Pandoraea is an emerging respiratory pathogen capable of causing chronic lung infections in people with cystic fibrosis (cf), but the clinical significance of this infection is ambiguous. |
| PubMedID- 21310671 | Anti-psa antibiotic therapy early in the course of psa infection in patients with cystic fibrosis (cf) may result in eradication of psa and prevention or delay of colonization with the organism. |
| PubMedID- 20098291 | The risk of mold infection was higher in patients with cystic fibrosis (11%, 4 of 35) than other underlying lung diseases (4%, 10 of 269). |
| PubMedID- 24068273 | Pseudomonas aeruginosa infection in patients with cystic fibrosis: scientific evidence regarding clinical impact, diagnosis, and treatment. |
| PubMedID- 23235684 | Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis. |